Company record · updated August 5, 2026
Candid, Inc: 1 valuation observation from SEC filings
Every row below names the filing it came from. Coverage for this company runs January 31, 2026 to January 31, 2026.
1observations
1source filings
1verified rows
2026-01-31most recent as-of date
Source rails for this company: N-PORT fund mark (1).
Reported by 1 filer: Franklin Biotechnology Discovery Fund.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2026-01-31 | price per share | 1.8 USD | Franklin Biotechnology Discovery Fund | VERIFIED | valUSD 2735296.2 / balance 1519609.0 [series b] | 000207169126007599 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.